Pharmacology In Drug Discovery And Development !!hot!! 〈HOT 2026〉

—pharmacologists ensure that a new drug is not only effective but also safe for human use. 1. The Core Pillars: PK and PD

A subset of systems pharmacology, QST predicts organ toxicity based on drug concentration at off-target receptors in the liver or kidney, allowing developers to design out toxicity.

: New studies on GLP-1 medications (like Ozempic) suggest they may offer unexpected pharmacological benefits for mental health, including reduced risks of depression and addiction. Core Resources for Deeper Insight pharmacology in drug discovery and development

: Researchers recently used generative AI to invent new antibiotics against drug-resistant strains like Staphylococcus aureus , marking a major step forward for antibiotic research.

If PD is the "what," then pharmacokinetics is the "where, when, and how long." PK describes the movement of a drug into, through, and out of the body over time, answering: The PK journey is captured by four critical processes, summarized by the acronym ADME : —pharmacologists ensure that a new drug is not

Using panels of 50+ receptors and ion channels (e.g., the CEREP panel), pharmacologists screen promising compounds for unwanted interactions. The most infamous example: terfenadine (Seldane), an antihistamine that blocked hERG potassium channels in the heart, causing fatal arrhythmias. Today, hERG screening is mandatory early in discovery.

How does the drug get in? Oral, intravenous, topical? Pharmacologists measure bioavailability (F), the fraction of the administered dose that reaches systemic circulation. A drug destroyed by stomach acid (e.g., insulin) must bypass the gut entirely. : New studies on GLP-1 medications (like Ozempic)

: Once a target is identified, it must be validated using techniques like CRISPR/Cas9 gene editing to prove that manipulating it will actually produce a therapeutic effect.

QSP allows researchers to build computational models that simulate physiological dynamics, accounting for variability across populations [5.1].

This accelerates lead optimization from months to days. However, pharmacology remains needed to validate in silico predictions with wet-lab assays.